Viewing StudyNCT00322374



Ignite Creation Date: 2024-05-05 @ 4:50 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00322374
Status: COMPLETED
Last Update Posted: 2016-03-10
First Post: 2006-05-01

Brief Title: Phase I Combination w Epirubicin
Sponsor: R-Pharm
Organization: R-Pharm

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-08
Start Date Type: None
Primary Completion Date: 2009-02
Primary Completion Date Type: ACTUAL
Completion Date: 2009-02
Completion Date Type: ACTUAL
First Submit Date: 2006-05-01
First Submit QC Date: May 4 2006
Study First Post Date: 2006-05-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2010-08-10
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-02-09
Last Update Post Date: 2016-03-10
Last Update Post Date Type: ESTIMATED